Outer membrane vesicles produced by Burkholderia cepacia cultured with subinhibitory concentrations of ceftazidime enhance pro-inflammatory responses

References

• Bach E, Sant’Anna FH, Magrich Dos Passos JF, et al. Detection of misidentifications of species from the Burkholderia cepacia complex and description of a new member, the soil bacterium Burkholderia catarinensis sp. nov. Pathog Dis. 2017;75:ftx076.
   Web of Science ®Google Scholar
• Sfeir MM. Burkholderia cepacia complex infections: more complex than the bacterium name suggest. J Infect. 2018;77(3):166–170.
   PubMed Web of Science ®Google Scholar
• Burkholder WH. Sour skin, a bacterial rot. Phytopathology. 1950;40:115–117.
   Web of Science ®Google Scholar
• Mohr CD, Tomich M, Herfst CA. Cellular aspects of Burkholderia cepacia infection. Microbes Infect. 2001;3(5):425–435.
   PubMed Web of Science ®Google Scholar
• Bottone EJ, Douglas SD, Rausen AR, et al. Association of Pseudomonas cepacia with chronic granulomatous disease. J Clin Microbiol. 1975;1:425–428.
   PubMed Web of Science ®Google Scholar
• Li Puma JJ. Burkholderia cepacia epidemiology and pathogenesis: implications for infection control. Curr Opin Pulmon Med. 1998;4:337–341.
   PubMedGoogle Scholar
• Tablan OC, Chorba TL, Schidlow DV, et al. Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J Pediatr. 1985;107(3):382–387.
   PubMed Web of Science ®Google Scholar
• Conly JM, Klass L, Larson L, et al. Pseudomonas cepacia colonization and infection in intensive care units. CMAJ. 1986;134(4):363–366.
   PubMed Web of Science ®Google Scholar
• Pegues DA, Carson LA, Anderson RL, et al. Outbreak of Pseudomonas cepacia bacteremia in oncology patients. Clin Infect Dis. 1993;16(3):407–411.
   PubMed Web of Science ®Google Scholar
• Kenna DTD, Lilley D, Coward A, et al. Prevalence of Burkholderia species, including members of Burkholderia cepacia complex, among UK cystic and non-cystic fibrosis patients. J Med Microbiol. 2017;66:490–501.
   PubMed Web of Science ®Google Scholar
• Abdallah M, Abdallah HA, Memish ZA. Burkholderia cepacia complex outbreaks among non-cystic fibrosis patients in the intensive care units: A review of adult and pediatric literature. Infez Med. 2018;26(4):299–307.
   PubMedGoogle Scholar
• Ramsey BW. Management of pulmonary disease in patients with cystic fibrosis. N Engl J Med. 1996;335(3):179–188.
   PubMed Web of Science ®Google Scholar
• Ganesan S, Sajjan US. Host evasion by Burkholderia cenocepacia. Front Cell Infect Microbiol. 2012;1:25.
   PubMed Web of Science ®Google Scholar
• Peeters E, Nelis HJ, Coenye T. In vitro activity of ceftazidime, ciprofloxacin, meropenem, minocycline, tobramycin and trimethoprim/sulfamethoxazole against planktonic and sessile Burkholderia cepacia complex bacteria. J Antimicrob Chemother. 2009;64:801–809.
   PubMed Web of Science ®Google Scholar
• Rajendran R, Quinn RF, Murray C, et al. Efflux pumps may play a role in tigecycline resistance in Burkholderia species. Int J Antimicrob Agents. 2010;36(2):151–154.
   PubMed Web of Science ®Google Scholar
• Golini G, Favari F, Marchetti F, et al. Bacteriostatic and bactericidal activity of levofloxacin against clinical isolates from cystic fibrosis patients. Eur J Clin Microbiol Infect Dis. 2004;23:798–800. .
   PubMed Web of Science ®Google Scholar
• Aaron SD, Ferris W, Henry DA, et al. Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia. Am J Respir Crit Care Med. 2000;161:1206–1212.
   PubMed Web of Science ®Google Scholar
• Lewin C, Doherty C, Govan J. In vitro activities of meropenem, PD 127391, PD 131628, ceftazidime, chloramphenicol, co-trimoxazole, and ciprofloxacin against Pseudomonas cepacia. Antimicrob Agents Chemother. 1993;37:123–125.
   PubMed Web of Science ®Google Scholar
• Zhou J, Chen Y, Tabibi S, et al. Antimicrobial susceptibility and synergy studies of Burkholderia cepacia complex isolated from patients with cystic fibrosis. Antimicrob Agents Chemother. 2007;51:1085–1088.
   PubMed Web of Science ®Google Scholar
• Tegos GP, Haynes MK, Schweizer HP. Dissecting novel virulent determinants in the Burkholderia cepacia complex. Virulence. 2012;3:234–237.
   PubMed Web of Science ®Google Scholar
• Thomson E, Dennis JJ. A Burkholderia cepacia complex non-ribosomal peptide-1 synthesized toxin is hemolytic and required for full virulence. Virulence. 2012;3:287–299.
   Web of Science ®Google Scholar
• Mahenthiralingam E, Urban TA, Goldberg JB. The multifarious, multirepliconBurkholderia cepacia complex. Nat Rev Microbiol. 2005;3:144–156.
   PubMed Web of Science ®Google Scholar
• Lagatolla C, Skerlavaj S, Dolzani L, et al. Microbiological characterization of Burkholderia cepacia isolates from cystic fibrosis patients: investigation of the exopolysaccharides produced. FEMS Microbiol Lett. 2002;209:99–106.
   PubMed Web of Science ®Google Scholar
• Haurat MF, Elhenawy W, Feldman MF. Prokaryotic membrane vesicles: new insights on biogenesis and biological roles. Biol Chem. 2015;396:95–109.
   PubMed Web of Science ®Google Scholar
• Jan AT. Outer membrane vesicles (OMVs) of gram-negative bacteria: a perspective update. Front Microbiol. 2017;8:1053.
   PubMed Web of Science ®Google Scholar
• Kulp A, Kuehn MJ. Biological functions and biogenesis of secreted bacterial outer membrane vesicles. Ann Rev Microbiol. 2010;64:163–184. .
   PubMed Web of Science ®Google Scholar
• Ellis TN, Kuehn MJ. Virulence and immunomodulatory roles of bacterial outer membrane vesicles. Microbiol Mol Biol Rev. 2010;74:81–94.
   PubMed Web of Science ®Google Scholar
• Mayrand D, Grenier D. Biological activities of outer membrane vesicles. Can J Microbiol. 1989;35:607–613.
   PubMed Web of Science ®Google Scholar
• Devos S, Van Putte W, Vitse J, et al. Membranevesicle secretion and prophage induction in multidrug-resistant Stenotrophomonas maltophilia in response to ciprofloxacin stress. Environ Microbiol. 2017;19:3930–3937.
   PubMed Web of Science ®Google Scholar
• Dutta S, Iida K, Takade A, et al. Release of Shiga toxin by membrane vesicles in Shigella dysenteriae serotype 1 strains and in vitro effects of antimicrobials on toxin production and release. Microbiol Immunol. 2004;48:965–969.
   PubMed Web of Science ®Google Scholar
• Yun SH, Park EC, Lee SY, et al. Antibiotic treatment modulates protein components of cytotoxic outer membrane vesicles of multidrug-resistant clinical strain,Acinetobacter baumannii DU202. Clin Proteomics. 2018;15:28.
   PubMed Web of Science ®Google Scholar
• Kaza SK, McClean S, Callaghan M. IL-8 released from human lung epithelial cells induced by cystic fibrosis pathogens Burkholderia cepacia complex affects the growth and intracellular survival of bacteria. Int J Med Microbiol. 2011;301:26–33.
   PubMed Web of Science ®Google Scholar
• Bamford S, Ryley H, Jackson SK. Highly purified lipopolysaccharides from Burkholderia cepacia complex clinical isolates induce inflammatory cytokine responses via TLR4-mediated MAPK signalling pathways and activation of NFkB. Cell Microbiol. 2007;9:532–543.
   PubMed Web of Science ®Google Scholar
• Mesureur J, Feliciano JR, Wagner N, et al. Macrophages, but not neutrophils, are critical for proliferation of Burkholderia cenocepacia and ensuing host-damaging inflammation. PLoS Pathog. 2017;13:e1006437.
   PubMed Web of Science ®Google Scholar
• Palfreyman RW, Watson ML, Eden C, et al. Induction of biologically active interleukin-8 from lung epithelial cells by Burkholderia (Pseudomonas) cepacia products. Infect Immun. 1997;65:617–622.
   PubMed Web of Science ®Google Scholar
• Tan K, Li R, Huang X, et al. Outer membrane vesicles: current status and future direction of these novel vaccine adjuvants. Front Microbiol. 2018;9:783.
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. M100 ED29:2019. Wayne, PA, USA: CLSI; 2019.
   Google Scholar
• Jin JS, Kwon SO, Moon DC, et al. Acinetobacter baumannii secretes cytotoxic outer membrane protein A via outer membrane vesicles. PLoS One. 2011;6:e17027.
   PubMed Web of Science ®Google Scholar
• Gerritzen MJH, Martens DE, Wijffels RH, et al. High throughput nanoparticle tracking analysis for monitoring outermembrane vesicle production. J Extracell Vesicles. 2017;6:1333883.
   PubMed Web of Science ®Google Scholar
• vanFaassen H, KuoLee R, Harris G, et al. Neutrophils play an important role in host resistance to respiratory infection with Acinetobacter baumannii in mice. Infect Immun. 2007;75(12):5597–5608.
   PubMed Web of Science ®Google Scholar
• Jun SH, Lee JH, Kim BR, et al. Acinetobacter baumannii outer membrane vesicles elicit a potent innate immune response via membrane proteins. PLoS One. 2013;8:e71751.
   PubMed Web of Science ®Google Scholar
• Porter LA, Goldberg JB. Influence of neutrophil defects on Burkholderia cepacia complex pathogenesis. Front Cell Infect Microbiol. 2011;1:9.
   PubMed Web of Science ®Google Scholar
• Allan ND, Kooi C, Sokol PA, et al. Putative virulence factors are released in association with membrane vesicles from Burkholderia cepacia. Can J Microbiol. 2003;49:613–624.
   PubMed Web of Science ®Google Scholar
• Cardona ST, Wopperer J, Eberl L, et al. Diverse pathogenicity of Burkholderia cepacia complex strains in the Caenorhabditis elegans host model. FEMS Microbiol Lett. 2005;250:97–104.
   PubMed Web of Science ®Google Scholar
• Bomberger JM, Maceachran DP, Coutermarsh BA, et al. Long-distance delivery of bacterial virulence factors by Pseudomonas aeruginosa outer membrane vesicles. PLoS Pathog. 2009;5:e1000382.
   PubMed Web of Science ®Google Scholar
• Nho JS, Jun SH, Oh MH, et al. Acinetobacter nosocomialis secretes outer membrane vesicles that induce epithelial cell death and host inflammatory responses. Microb Pathog. 2015;81:39–45.
   PubMed Web of Science ®Google Scholar
• Kim YJ, Jeon H, Na SH, et al. Stenotrophomonas maltophilia outer membrane vesicles elicit a potent inflammatory response in vitro and in vivo. Pathog Dis. 2016;74:ftw104.
   PubMed Web of Science ®Google Scholar
• Nieves W, Asakrah S, Qazi O, et al. A naturally derived outer-membrane vesicle vaccine protects against lethal pulmonary Burkholderia pseudomallei infection. Vaccine. 2011;29(46):8381–8389.
   PubMed Web of Science ®Google Scholar
• Punj V, Sharma R, Zaborina O, et al. Energy-generating enzymes of Burkholderia cepacia and their interactions with macrophages. J Bacteriol. 2003;185(10):3167–3178.
   PubMed Web of Science ®Google Scholar
• Hutchison ML, Poxton IR, Govan JR. Burkholderia cepacia produces a hemolysin that is capable of inducing apoptosis and degranulation of mammalian phagocytes. Infect Immun. 1998;66:2033–2039.
   PubMed Web of Science ®Google Scholar
• Goh EB, Yim G, Tsui W, et al. Transcriptional modulation of bacterial gene expression by subinhibitory concentrations of antibiotics. Proc Natl Acad Sci USA. 2002;99(26):17025–17030.
   PubMed Web of Science ®Google Scholar
• Yim G, McClure J, Surette MG, et al. Modulation of Salmonella gene expression by subinhibitory concentrations of quinolones. J Antibiot (Tokyo). 2011;64(1):73–78.
   PubMed Web of Science ®Google Scholar